🔗 Share this article

This year's prestigious award in medical science was awarded for revolutionary discoveries that illuminate how the body's defense network attacks harmful infections while sparing the healthy tissues.

Three esteemed researchers—Japan's Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The research identified unique "security guards" within the defense system that remove malfunctioning immune cells capable of attacking the body.

These discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

The winners will share a monetary award valued at 11m SEK.

Crucial Findings

"Their work has been essential for comprehending how the body's defenses functions and the reason we do not all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

This trio's research address a core mystery: How does the immune system protect us from countless infections while leaving our own tissues unharmed?

Our immune system uses immune cells that scan for indicators of disease, including pathogens and bacteria it has never encountered.

These cells employ detectors—called receptors—that are generated randomly in a vast number of variations.

That provides the defense network the capacity to fight a broad range of invaders, but the unpredictability of the process unavoidably creates white blood cells that can attack the body.

Protectors of the Immune System

Researchers previously knew that some of these harmful defense cells were eliminated in the immune organ—where immune cells develop.

This year's award honors the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to disarm any immune cells that attack the healthy cells.

It is known that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "The discoveries have established a new field of investigation and accelerated the development of new therapies, for example for cancer and immune disorders."

In malignancies, T-regs prevent the system from attacking the growth, so research are aimed at lowering their quantity.

In self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer under attack. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, from a Japanese institution, conducted tests on mice that had their immune gland extracted, causing self-attack conditions.

He showed that injecting defense cells from other animals could stop the disease—implying there was a mechanism for blocking defenders from attacking the host.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in mice and people that resulted in the identification of a gene vital for the way T-regs function.

"The pioneering research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science expert.

"This work is a remarkable illustration of how fundamental biological research can have broad implications for public health."